# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-001389
Filing Date
2022-05-13
Accepted
2022-05-12 19:31:01
Documents
70
Period of Report
2022-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | mrkr-20220331x10q.htm iXBRL | 10-Q | 993886
2 | EX-10.1 | mrkr-20220331xex10d1.htm | EX-10.1 | 47051
3 | EX-31.1 | mrkr-20220331xex31d1.htm | EX-31.1 | 13115
4 | EX-31.2 | mrkr-20220331xex31d2.htm | EX-31.2 | 14226
5 | EX-32.1 | mrkr-20220331xex32d1.htm | EX-32.1 | 7498
6 | EX-32.2 | mrkr-20220331xex32d2.htm | EX-32.2 | 7495
7 | GRAPHIC | mrkr-20220331x10q002.jpg | GRAPHIC | 47515
8 | GRAPHIC | mrkr-20220331x10q001.jpg | GRAPHIC | 9834
| Complete submission text file | 0001410578-22-001389.txt |  | 4766515

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | EX-101.SCH | mrkr-20220331.xsd | EX-101.SCH | 43637
10 | EX-101.CAL | mrkr-20220331_cal.xml | EX-101.CAL | 36382
11 | EX-101.DEF | mrkr-20220331_def.xml | EX-101.DEF | 123378
12 | EX-101.LAB | mrkr-20220331_lab.xml | EX-101.LAB | 281619
13 | EX-101.PRE | mrkr-20220331_pre.xml | EX-101.PRE | 243920
64 | EXTRACTED XBRL INSTANCE DOCUMENT | mrkr-20220331x10q_htm.xml | XML | 710269

Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37939 | Film No.: 22919645
SIC: 2834 Pharmaceutical Preparations